Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Diesel Fumes Aggravate Response to Airborne Allergens

By Biotechdaily staff writers
Posted on 29 Jan 2004
Researchers studying the genetic factors that determine the risk of developing allergies have used a model system combining ragweed pollen with diesel fumes to show that individuals with defects in the family of antioxidant-related genes (GSTM1, GSTT1, and GSTP1) are more likely to suffer allergic reactions than those with normal GST activity.

Investigators at the University of Southern California (Los Angeles, USA; www.usc.edu) exposed volunteers with ragweed allergy to controlled doses of ragweed pollen followed by either a placebo or by diesel exhaust particles equivalent to breathing the air in Los Angeles for 40 hours. More...
Nasal allergen-specific IgE, histamine, interleukin 4, and interferon-gamma concentrations were measured before and 24 hours after challenge. Genomic analyses were performed to determine which genes became activated.

Results published in the January 10, 2004, issue of The Lancet revealed that the mix of ragweed and diesel exhaust triggered greater allergic responses than ragweed alone. Individuals lacking GSTM1 or carrying the GSTP1 I105 wild type genotype showed enhanced nasal allergic responses in the presence of diesel exhaust particles. Compared with patients with a functional GSTM1 genotype, patients lacking GSTM1 had a significantly larger increase in IgE and histamine.

"Diesel emissions can trigger allergic symptoms, but the genetic factors involved in the process are quite complex,” explained senior author Dr. David Diaz-Sanchez, assistant professor of immunology and allergy at the University of Southern California. "Our findings suggest that people who lack the genes to make key antioxidants may have difficulty fighting the harmful effects of air pollution.”



Related Links:
University of Southern California

Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
hCG Whole Blood Pregnancy Test
VEDALAB hCG-CHECK-1
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.